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Human cells remove  bulky  adducts  from DNA by ex- 
cising single-stranded fragments 27-29 nucleotides in 
length by an enzyme system consisting of at least 14 
polypeptides.  All  of  the  previous  work  on  characterizing 
the  excision  reaction was  conducted  with  plasmids  3  or 
8 kilobases in length. To determine  if  the  size  and  terti- 
ary  structure  of DNA play a  role  in  the  excision  reaction 
and  to  find  out  if  large DNA fragments  are  necessary  to 
contact  all of the  subunits of the  excinuclease,  we  per- 
formed  experiments  with  circular DNA and  with  linear 
DNA fragments  of  various sizes. We found  that  the  hu- 
man excinuclease is capable  of  removing DNA adducts 
from linear  and  covalently  closed  circular DNAs with 
about  the  same  efficiency.  Furthermore,  we  found  that 
the  excinuclease  can  remove  a  thymine  dimer or a  pso- 
ralen-thymine  monoadduct  from  linear  fragments  pro- 
vided  that  the  distance  between  the  lesion  and  the 5‘- 
terminus  of  the  damaged  strand is 260 nucleotides  and 
the  distance  between  the  lesion  and  the  3“terminus is 
244 nucleotides.  Thus,  the  minimum  size  substrate  for 
human  excinuclease is “100  base  pairs  in  length. 
Nucleotide  excision  repair is the sole  mechanism  for  remov- 
ing bulky adducts from human DNA. The basic reaction is 
relatively  simple.  The 22-24th phosphodiester  bond 5’ and the 
5th phosphodiester bond 3’ to the lesion are hydrolyzed to 
release a 27-29-ntl-long oligomer containing the damaged 
nucleotide  (Huang et  al.,  1992);  yet,  genetic (Cleaver and Krae- 
mer,  1989) as well as biochemical  (Reardon et al., 1993)  studies 
indicate that at least 14  proteins  are  required  to  carry  out  the 
dual  incision  reactions.  Although  some data exist  on the prop- 
erties of the individual subunits, there is, as yet,  no  defined 
system  for human excision  repair in  vitro. All of the in  vitro 
repair studies have been conducted with cell-free extracts 
(Hoeijmakers et al., 1990;  Reardon et al.,  1993) and with co- 
valently closed plasmid DNA of -3 kilobase pairs or more. 
Considering the number of subunits involved and assuming 
that all of the subunits would be present in the excision com- 
plex  (“repairosome”)  simultaneously,  one  might  expect that a 
relatively large size DNA would be required  for the necessary 
contacts  to be made and the excision  reaction  to occur. In ad- 
dition,  since the natural substrate  for the human excinuclease 
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is supercoiled nucleosomal DNA, it is conceivable that DNA 
fragments that are too  short  for  imposition of local  superhelic- 
ity  may  not  act as substrates  for  the  human  excinuclease  sys- 
tem. To answer these and related questions,  we  conducted re- 
pair experiments with circular DNA and with fragments of 
various sizes containing  two  different types of lesions. 
Our results  show that circular and linear DNAs containing a 
thymine dimer (ToT) are repaired with equal efficiencies. 
Similarly, DNA fragments containing a single psoralen-thy- 
mine furan side adduct are repaired efficiently. By using re- 
striction  fragments  containing the lesions at various  distances 
from  the 3’- or 5‘-termini, we  were  able  to  demonstrate that the 
human  excinuclease  removes damage provided that the lesion 
is 260 nucleotides  from the 5”terminus and 244 nucleotides 
from  the 3’4erminus of the  damaged  strand. 
MATERIALS AND METHODS 
Substrates-We used  two classes of substrates, one containing a cy- 
clobutane thymine dimer (ToT)  and one containing a 4“hydroxy- 
methyl-4,5‘,8-trimethylpsoralen-thymine furan side monoadduct 
(ToHMT). The ToT-containing plasmid substrate was prepared as 
described  previously (Huang et al., 1992) using a 20-mer ( T o T )  of the 
sequence GCAGCTGACGToTAATAGCTC prepared by the method of 
Taylor et al. (1987) as the primer for second strand synthesis. The 
oligomer was a kind giR of Drs. J.3. Taylor and D.  L.  Svoboda (Wash- 
ington University, St. Louis, MO). Fragments containing a single T o T  
were obtained by digesting the plasmid with the appropriate restriction 
enzymes. The ToHMT substrate was prepared by ligating a do- 
decamer (GAAGCTACGAGC) containing a ToHMT adduct, kindly 
provided by Dr. J. E. Hearst (University of California, Berkeley,  CA), 
with seven other oligomers as described  previously (Shi et al., 1987; Van 
Houten et al., 19871, except that the two arm oligomers  were  69 nt (top) 
and 64 nt (bottom) in length such that the length of the assembled 
duplex was 156  bp. It must be noted that because of the difference in 
sizes of the oligomers  used  to make the T o T  and ToHMT substrates, 
the radiolabels are  at the 11th and  6th phosphodiester bonds 5’ to the 
lesion in  the two substrates, respectively. 
Excision Assuy-This assay measures the release of radiolabeled 
fragments carrying the lesions, and it was conducted with both human 
cell-free extract (CFE) and purified Escherichia  coli UvrA,  UvrB, and 
UvrC proteins. The  excision assay with human CFE prepared by the 
method of Manley et al. (1980) was conducted as follows (Huang et al., 
1992). The reaction mixture (50 4, unless indicated otherwise) con- 
tained 40 mM HEPES, pH 7.9,70 mM KC1,8 m MgCl,, 2 mMATP,  20 PM 
each dNTP,  1.2 l ~ l ~  dithiothreitol, 0.3 m EDTA, 10% (v/v)  glycerol, 100 
pg/ml  bovine serum albumin, 5 units of pyruvate kinase, 50 pg  of phos- 
phoenolpyruvate, 2-5 x lo4 cpm  (100-200  ng) substrate,  and 100 pg of 
HeLa CFE proteins. The mixture was incubated at 30 “C for  90 min 
unless indicated otherwise, and following deproteinization by protein- 
ase K digestion and phenokhloroform extraction, the products were 
with the E. coli (A)BC excinuclease  (Thomas et al.,  1985) was conducted 
analyzed on 10% polyacrylamide sequencing gels. The excision assay 
in 25  pl of AEK buffer containing 50 mM Tris-HC1,  pH 7.5, 50 mM KCl, 
10 mM MgCl,, 2 mM ATP, 10 dithiothreitol, 100 pg/ml bovine serum 
albumin, and  3 x lo3 cpm substrate plus 5 nM UvrA,  40 nM UvrB, and 
50 m UvrC.  The reaction mixture was incubated at 37 “C  for  30 min 
and lyophilized, and then the DNA was separated on  10%  polyacrylam- 
ide sequencing gels.  The  level of excision  was quantified by densitom- 
etry of the autoradiograph or by an AMBIS scanner. The area covering 
the 15-30-nt  region was scanned for the  human excinuclease, and the 
intensity of the 12-nt-long band was taken to be a measure of the E. coli 
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Fa. 1. Cyclobutane thymine dimer substrates. The plasmid 
pUNC1991-4 ( T o T )  contnins four  TOTS within a 761-bp  region.  Di- 
gestion of the plasmid with HaeIlI (H) generates three fragments of 914 
tfragments I and 11). 104 (fragment 111). and  164 (fragment IVI  bp. The 
914-bp fragment was further digested with RsnI ( R )  to yield fragments 
I (618 bpl and I1 (296 bp,. The lower part of the figure shows the 
distances between the T o T s  and the 5 ' -  and 3"termini of the damaged 
strand. 
(A)BC  excinuclease activity on the ToHMT substrate. Since the T o T  
substrate contains the radiolabel at the 11th phosphodiester bond 5' to 
the lesion, the excised fragment is not radiolabeled; the excision reac- 
tion by (A)RC excinuclease generates a 90-nt-long radiolabeled frag- 
ment from this  substrate, and the intensity of this fragment was taken 
to be a measure of the (A)RC excinuclease activity on the ToT 
substrate. 
RESULTS 
Linear Suhstrates for Excision Assay-Linear substrates 
with T o T  were  generated  by  digesting  plasmid  DNA  contain- 
ing four T o T s  at predetermined positions with appropriate 
restriction enzymes. The plasmid pUNC1991-4 (4.3 kilobase 
pairs)  contains  four T o T s  within a region of 761  bp  (Huang  et 
al., 1992). By digesting  this  plasmid  with  HaeIII  plus RsaI, we 
generated  four  fragments of 618, 296,  164,  and  104  bp,  each 
carrying  one of the T o T s  (Fig. 1). The  164-bp  fragment con- 
tained  convenient  restriction  sites  for  trimming  the DNA on 
either  side of the  lesion,  and  therefore,  it  was  used  for  gener- 
ating  smaller  fragments  to  define the length  requirement for 
the  human excinuclease. 
The  linear  substrate  with a ToHMT  was   ob ta ined  by  ligat- 
ing eight synthetic oligomers (Shi et al., 1987). This 156-bp 
fragment  was  designed  with  unique  restriction  sites at every 10 
bp  from  the  5'-end of the  damaged  strand.  Digestion  with  ap- 
propriate restriction enzymes generated a series of shorter 
fragments (see below)  for the  excision  assay  designed to define 
the  minimum  5"flanking  length  required  for  excision. 





FIG. 2. Time course of excision reaction. Fragment IV (164 bp) 
was incubated with 300 pg of CFE in 150 pl of reaction mixture. Fifty-pl 
aliquots (4  x 10' cpm) were trlken at the indicated times, and the 
reaction products were  analyzed on a 105 polyacrylamide  sequencing 
gel. The leftmost lane contains a 30-mer size marker. 
lime Course of Excision ReactionCince  this  study involved 
the  comparative efficiency of repair of various  substrates, we 
wished to determine the optimal conditions for the excision 
activity. We have  found  that 100-150 pg of CFE  protein  gives 
an  optimal  signal  (1-29 of the  adduct  excised)  (Reardon et al., 
1993),  and  therefore,  100 pg of CFE  was  used  in  the  present 
work. To find  out if we could conduct  kinetic  experiments (rate) 
to  compare  the  efficiencies of various  substrates,  we  measured 
the  level of excision  with  fragment IV (164  bp)  as a function of 
time.  The  result  is  shown  in Fig. 2. ' b o  conclusions emerge 
from  this figure. First,  the  apparent level of excision does  not 
appear to increase  after 1 h of incubation.  In  fact,  integration of 
the  fragment  in  the 30-15-nt region  revealed  relative excision 
of 1,  0.66,  and 0.38 for 1-, 2-, and 3-h time  points, respectively. 
Second,  the  pattern of the excised  fragments  changes.  The  two 
phenomena are related  and are due  to  degradation of the ex- 
cised  fragments by nonspecific  nucleases  in  CFE  (Huang  et al., 
1992;  Nichols  and  Sancar,  1992;  Svoboda et al., 1993a).  From a 
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practical standpoint,  this  experiment  reveals  the difficulty of 
conducting a kinetic experiment with the excision assay. At 
longer time points, a large fraction of the excised oligomer is 
degraded down to mononucleotides, and  since  the  smaller f ag- 
ment.   (<lo  nt)   are also  generated  in  substantial  amounts by 
random  degradation of the  substrate itself, it is not possible to 
quantify excision by integrating the radioactivity over the 
range of 1-30 nt.  Thus, we decided to conduct our  substrate 
preference experiments by measuring  the level of excision a t  a 
single  time point (90 min), which we have found to yield an 
optimal  signal  in most experiments. 
Relative Efficiencies of  Circular  and  Linear DNAs-The cir- 
cular plasmid pUNC1991-4 and  three  fragments derived from 
this plasmid  were  compared in  an excision assay. The 104-bp 
fragment (111) was a poor substrate  presumably because of the 
short 3”flanking sequence (see below), making quantitative 
analysis of the  repair of this  fragment  rather difficult. There- 
fore, only the  other  three  fragments were  used in  this study. By 
using  equal  amounts of radiolabel in the  assays, we assured 
that  the  substrate concentration was  identical  in  the  compara- 
tive  quantitative  analyses since the  same “‘P-labeled 20-mer 
primer  was  the source of lesion in  all of the  substrates. 
The  results  are shown in Fig. 3. There is no systematic dif- 
ference  between the  circular  and  linear forms or between linear 
forms of various  lengths. Of special note  is  the  fact  that a T o T  
is excised with  about  equal  eficiency from the  circular  plasmid, 
which contains four T o T s  within a region of 761  bp (or T o T  
density of  11190 bp),  and from a fragment of 618 bp  carrying a 
single T o T ,  suggesting  that T o T  density does not  determine 
relative efficiency of excision and  that  circular DNA is not  re- 
paired  more efficiently than  the  linear  substrate by the  human 
excinuclease. Quantitative analysis of the excision in Fig. 3 
(lanes 2 4 )  revealed relative efficiencies of excision of 540  for 
fragment I1 (297 bp)  and 400  for fragment N (164  bp)  relative 
to  the excision level of covalently closed circular DNA. How- 
ever, even this difference is probably due to experimental  var- 
iability in  this ill-defined system. As seen  in Fig. 3 (lanes 5-7, 
which were  obtained from an  independent  experiment  under 
similar conditions), the excision levels for the  linear  fragments 
were 8 2 0  (fragment I), 35% (fragment II), and 110% (fragment 
N) compared  with circular DNA (lane 2) with four T o T s .  
In  addition, Fig. 3 shows  some  variability  in  the  distribution 
of the  length of the excised fragments  depending on the  sub- 
strate. We ascribe  this to the sequence effect on the precise site 
of the incision 5‘ to the lesion  because all of the TOTS have  the 
same sequence at  and  around  the 3”incision sites and different 
sequences  around  the 5”incision sites  due to the way the  sub- 
strate  is  constructed  (see Fig. 2 in  the  study of Huang et al. 
(1992)).  These different sequences  might be responsible for the 
different excision patterns. 
Minimum  Substrafe  Size-Of the  three  fragments used in 
Fig. 3, the 164-bp HaeIII fragment (IV) contained  unique re- 
striction sites that were  convenient for delineating  the  minimal 
size substrate. In the full-length fragment,  the T o T  is  84  bp 
from the  5“terminus  and  78  bp from the  3’-terminus (Fig. 4A ). 
Digestion with HinPI leaves the  distance 5’ to T o T  intact,  but 
reduces  the  distance 3’ to T o T  to 44 bp. As shown in Fig. 4B, 
this  has only a small effect on excision efficiency (72% of the 
full-length fragment).  In  contrast, digestion  with MaeIII, which 
reduces  the  3”flanking sequence to  28 bp, reduces  the excision 
eficiency to -10% of the full-length fragment.  There  was only 
one convenient site 5’ to  the T o T  in  this  fragment. RsaI di- 
gestion reduces the 5’-flanking sequence to 52 bp, and this 
reduction in  the  size of the  5”flanking  sequence  reduces  the 
excinuclease activity to barely above the background level (Fig. 
4R, lane 4 ). These  results combined lead to the conclusion that 
0 
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FIG. 3. Removal of ToT from circular and linear substrates by 
human excinuclease. pUNC1991-4 (TOT) and  restriction  fragments 
I (618  bp), 11 1296 bp),  and  IV(lf4  bp) were  incubated  with MeLa CFE 
for 90 min at 30 -C and, following deproteinization.  were  analyzed on a 
109 polyacrylamide  sequencing gel. rn, 30-nt-long  size  marker. Lanes 
2 4  (5 x 10‘ cpm each) contained  samples from the  same  experiment. 
Lanes .5-7 ( 5  x 10:’ cpm each) contained samples from a separate 
experiment. 
-44 bp of 3”flanking DNA and >50 bp of 5”flanking DNA are 
required for the optimal  activity of human excinuclease. 
Psoralen-adducted DNA for Precise Delineation of  Substrate 
Size-Although the 164-bp fragment  was useful in  establishing 
a relatively precise boundary for the  length of the  3”flanking 
sequence, it was not particularly useful in defining the 5‘- 
flanking  length for optimal activity. To define the boundaries 
more precisely, we synthesized a substrate with  a unique re- 
striction site a t  every 10 bp 5’ to the lesion (ToHMT)  and 
conducted excision assays on this  substrate following digestion 
with  the  appropriate enzymes. Fig. 5A shows the  map of the 
resulting  fragments,  and Fig. 5B shows the level of excision ac- 
tivity obtained for each fragment following incubation  with hu- 
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A 
FIG. 4. Delineation of flanking se- 
quence length dependence of exci- 
sion of To" by human excinuclease. 
The  numbers I ,  75. ; ~ n d  16.1 indicate  the 
5'-terminus,  the position of the label,  and 
the 3'-terminus, respectively. The num- 
bers at   the corners of the boxes indicate 
the  distnnces from the  corresponding re- 
striction  site  termini  to  the lesion. H ,  
Rsal; M ,  MaeIlI; If, HinPI. A, restriction 
map of fragment IV (164 bp) used in this 
study.  The + and t sinns indicate  whether 
the  fragment  cut at   that  position was an 
optimal or marginal  substrate  relative to 
the full-size fragment. respectively. B.  
analysis of excision reactions with frag- 
ment IV undigested ( - )  or  digested  with 
the indicated  enzymes  and  then  subjected 
to the  repair  reaction  with  HeLa CFE. In 
lane 3,  the original autoradiograph re- 
vealed primary excision producLq. a t   the  
positions  indicated by thrcv asterisks, 
which are not discernible in this photo- 
graphic  reproduction.  Each 
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man CFE and purified E. coli (A)BC excinuclease, which was 
used as  a control. For the  human enzyme, taking  the  average 
efficiencies of excision of two experiments  including  the one 
shown in Fig. 5R (lanes 1-7) and  using  the level of excision from 
the full-length fragment  (the lesion is  92  nt from the  5'-end  and 
62 n t  from the  3'-end)  as  1008,  the  relative fficiencies of ex- 
cision from truncated  fragments were as  follows: 75% (80  nt 5'), 
90% (70 nt 5'), 86% (60  nt 5'), 8% (50 nt 5'), 4% (28  nt 3'), and 
<1% (for a fragment with  25 nt 3' to  the lesion). We conclude that 
a fragment of -90 bp  with  60 bp of 5"flanking sequence  and  30 
bp of 3"flanking sequence is the  minimum  essential  substrate 
for excision and  that a substrate with 60 bp of 5"flanking se- 
quence and  44 bp of 9"flankingsequence is sufficient for optimal 
activity by the  human excinuclease.  Considering that  the  main 
incision sites of this enzyme are 22 nucleotides 5' and 4  nucle- 
otides 3' to  the lesion, the  lengths of the  flanking sequences for 
optimal incision are  35-40 bp from the incision sites. 
In contrast, and in agreement with an earlier study (Van 
B !ui 
a 
1 2 3  4 
Houten et al., 1987), 5'- and 3"flanking  sequences of 25 bp are 
sufficient for optimal excision by the E. coli (ABC excinuclease. 
In  fact,  deletion of the sequences beyond 25 bp 3'  to  the lesion 
improved the efficiency of the E. coli enz-yme, presumably be- 
cause deletion of this sequence facilitates  the dissociation of 
(UvrA), from the &R,-DNA nonproductive preincision complex 
to yield the productive UvrB-DNA preincision complex (Rer- 
trand-Rurggraf et al., 1991). 
Substrate Preference-With the E. coli excinuclease, it has 
been found that  the most abundant UV photolesion, the cis..vn- 
pyrimidine  dimer, is not  a particularly good substrate for the 
enzyme in most sequence contexts (Svoboda et al., 1993b3, 
whereas  the T o H M T  substrate is a  relatively good substrate 
(Van Houten et al., 1987). It  was therefore of interest to deter- 
mine if the human excinuclease, like the E. coli (A)BC ex- 
cinuclease, preferred T o H M T  over T o T .  The 164-mer ( T o T )  
and  the 156-mer (ToHMT)  were incubated with either HeLa 
CFE or (A)BC excinuclease, and the reaction products were 
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FIG. 5. Effect of subtrate length on excieion of ToHMT by human excinuclease and by E. coli (A)BC excinuclease. A, restriction 
map of the substrate. The label (asrerisk) is at  the  6th phosphodiester bond 5' to the adduct (88th phosphate from the fi'-terminus). The 
distances  between  the  restriction  sites  and  the  psoralen  adduct  are  indicated by the  numbers  outside  the boxes, and  whether  the DNA digested 
by those  restriction  enzymes is substrate for the  human  excinuclease is indicated by + (optimal), * (marginal),  and - (not  a  substrate) signs. M ,  
MluI-digested DNA; E ,  EcoRV-digested D N A  If, HincII-digested DNA; N. NcoI-digested DNA; X, XbaI-digested DNA; E. BgIII-digested DNA. R,  
reaction  products of fragments  treated  with  either  HeLa CFE (lanes 1-7; 3 x 10' cpm) or (A)BC excinuclease (lanes 8-14; 3 x 10'  cpm). Lanes 1 
and R contain DNA not  digested  with  a  restriction  enzyme (-). Excision products  were  separated on a 1 0 3  polyacrylamide sequencing gel. The high 
molecular  mass  bands  seen  in the HincII-digested DNA (lanes 4 and 11)  are  side products of the HincII  digestion  and  are  present  in D S A  not 
treated  with HeLa CFE or (A)BC excinuclease.  The 27-29-mer main excision products of the  human excinuclease  and  the  12-mer xcision product 
of (A)RC excinuclease are indicated. Note that  the reactions  with (A)RC excinuclease  contained IO? of the  substrate employed in the  human 
excinuclease  reactions. 
analyzed. Fig. 6 shows that while in  these  particular sequence strate of the  human excinuclease by a  factor of 2. Thus, we 
contexts, T o T  and ToHMT are excised with about equal conclude that  the two enzymes have different specificities and 
efficiencies by (A)RC excinuclease, T o T  is  the preferred sub- that  the poor repair of T o T s  in randomly  damaged DNA in 
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FIG. 6. Effect of lesion type on  excision  efflciency of human 
and E. coli exeinucleasen. The 164-mer (TOT) or the 156-mer 
( T o H M T ,  were  incubated  either  with HeLa CFE  at  30 "C for 90 min  or 
with UvrA ( 5  nw), UvrB (40  nM), and UvrC (50 nu)  at   37 "C for 30  min, 
and  the  reaction  products  were  analyzed on a 10'7 polyacrylamide se- 
quencing gel. Equal  counts (3 x 10' cpm) of the two  substrates  were 
employed in the  reactions  with  HeLa  CFE.  and 1O"r of these  counts 
were included in the reactions with (A)RC excinuclease. The human 
excinuclease tH-EXC) releases 27-29-nt-long labeled oligomers from 
both substrates.  The  slower  migration f t h e   T o H M T  excision producb 
in lane 5 in this gel is an experimental  artifact  (see Fig. 5 8  ). The E. coli 
(A)RC excinuclease releases a labeled 12-mer carrying the ToHMT 
from the psornlen substrate, which contains a 'T' label at the 6th 
phosphate 5' to the  adduct; however, excision ofa  13-mer  containing  the 
T o T  from the 164-mer, which contains  the  radiolabel a t   the  11th phos- 
phodiester bond 5' to the lesion, generates a 90-nt-long radiolabeled 
fragment. 
vitro by the  human excinuclease (Sibghat-Ullah et al., 1989; 
Wood. 1989) probably results from the  strong competition by the 
much better (6-4) photoproduct substrate  rather  than from an 
intrinsic poor repairability of cyclobutane  pyrimidine  dimers. 
DISCUSSION 
Recent studies  have revealed that  the  human excinuclease 
system involves, in addition to XP proteins  and ERCC1, the 
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entire  transcription factor IIH, which is  made  up of eight  sub- 
units including XPR, XPD, and XPC (Schaeffer et al., 1993; see 
Drapkin et al. (1994)). Thus, a t  least 14 polypeptides must 
cooperate  to make  the two  incisions characteristic of the  human 
excinuclease (Huang et al., 1992). Whether all of the proteins 
make an organelle (repairosome) that carries out the entire 
nucleotide excision repair reaction in a concerted manner or if 
the  various  proteins involved function in a sequential  manner 
is  not known. Only by using defined substrates  and purified 
proteins  can  these  and  related  questions be answered. 
We previously  reported the construction of a substrate con- 
taining four T o T s   a t  unique locations in a plasmid molecule 
for this  purpose  (Huang et al. ,  1992). While this  substrate  en- 
abled us  to  determine  the incision sites of the  human excinucle- 
ase,  it  was  not  suitable for addressing more detailed  questions 
regarding  the reaction  mechanism of the enzyme  such as  sub- 
strate preference and  subunit  contact  sites.  Furthermore,  the 
construction of the  substrate  was too cumbersome and  time- 
consuming to be of use in routine assays for purifying the 
enzyme and  its  subunits.  Here, we show that  neither  multiple 
T o T s  in a  plasmid nor  circular DNA is necessary for an effi- 
cient  substrate for the excision assay. Furthermore, since the 
enzyme  repairs  all bulky adducts,  virtually  any bulky adduct 
that  can be incorporated into a fragment of -100 bp can be 
used as  substrate.  The employment of these  types of substrates 
has  already helped answer  several  important  questions  regard- 
ing the structure and function of the human excinuclease. 
These  are briefly recapitulated below. 
Our finding that  the minimum  size substrate  is -100 bp in 
length is more consistent with a sequential action of the 14 
polypeptides of the excinuclease, perhaps  in  the form of subas- 
semblies. Thus,  the  eight polypeptides making  up  the  "repair 
form" of transcription factor IIH, which includes XPB, XPC, 
and XPD, may function at  an  early  stage  (Schaefferet al., 1993; 
see  Drapkin et al. (1994) and also Feaver et al.  (1993)), deliv- 
ering  the  subunits or the  subassemblies with a nuclease  active 
site to perform their functions a t  later stages. The damage 
recognition subunit XPA (Jones  and Wood, 1993; Guzder et al. ,  
1993) makes a ternary complex with ERCCl and ERCC4 (XPF) 
(Park and Sancar, 1994). The RAD10 and RAD1 proteins, 
which are homologs of ERCCl and ERCC4 (XPF), respectively, 
make a heterodimer with  single  strand-specific  nuclease  activ- 
ity (Tomkinson et al., 1993; Sung  et al., 1993). Similarly. the 
yeast RAD2 protein, which is  the XPG homolog, has nuclease 
activity (Habraken et al., 1993). Thus,  it  is  quite possible that 
the  damage recognition, potential conformational change in the 
form of unwinding  and  kinking of the DNA at   the  damage  site, 
and finally, endonucleolytic scission are not camed  out in one 
multiprotein complex, but  rather  through  the action of indi- 
vidual polypeptides or polypeptide assemblies (factors) in a 
sequential and partly overlapping manner. Such an action 
mechanism is more consistent with  a  minimum substrate size 
of - 100 bp. It  is unlikely that  all of the excision repair  proteins 
totaling - 10' Da in molecular mass could assemble on a DNA 
molecule of only 100 bp. In E. coli, the combined mass of the two 
proteins  (UvrB  and C 'v rC)  that  remain bound during  the inci- 
sion  reaction is -150 kDa,  and  the minimum  size for optimal 
incision is -50 bp (Van Houten et al., 1987). However, i t  is also 
possible that  the  human excision repair  system mechanistically 
is  quite  different from the prokaryotic  system. Thus,  the  entire 
set of human excision repair proteins may make a complex 
(repairosome)  in which only some of the  subunits contact the 
DNA, and hence, a fragment of -100 bp is sufficient to  make  all 
the necessary  contacts. Further  research with  a better defined 
system  is needed to resolve these issues. 
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Another conclusion that emerges from this study is that a 
single  pyrimidine dimer  in a DNA molecule is a relatively good 
substrate for the  human excinuclease. An earlier study, which 
failed to detect a repair  signal  with a uniquely placed thymine 
dimer  in a plasmid (Szymkowski et al., 1993), was conducted 
with  the  repair  synthesis a say, which is  less sensitive and  less 
specific than  the excision assay (Reardon et al., 1993). In fact, 
our results show that the human excinuclease repairs the 
ToT-containing DNA more efficiently than  the  ToHMT ad- 
duct-containing DNA. This is in  contrast  with  the E. coli (A)BC 
excinuclease, where in most  sequence  contexts (but  apparently 
not in  the one employed in  this work), the  ToHMT is excised 
-5-fold more efficiently than a T o T  (Bertrand-Burggraf et al., 
1991; Svoboda et al., 1993b). We wish to  stress, however, that 
while our  data  regarding  the efficient repair of T o T  by the 
human excinuclease and different substrate preferences of hu- 
man  and E. coli excinucleases are  real,  these  statements  must 
be considered qualitative a t  this point. We believe that  true 
quantitative  statements can be made only when  kinetic experi- 
ments  are  carried  out  with defined systems. 
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